16:40 EST Applied Therapeutics (APLT) trading resumes
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT:
- Applied Therapeutics’ NDA for govorestat receives negative response from FDA
- Applied Therapeutics trading halted, news pending
- Applied Therapeutics price target raised to $13 from $11 at Citi
- RBC says if Applied’s govorestat were to be approved, would likely hear today
- Applied Therapeutics Advances with Govorestat Approvals